Multiomics analysis of tumor mutational burden across cancer types

Whether tumor mutational burden (TMB) is related to improved survival outcomes or the promotion of immunotherapy in various malignant tumors remains controversial, and we lack a comprehensive understanding of TMB across cancers. Based on the data obtained from The Cancer Genome Atlas (TCGA), we cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Bai, Long, Lin, Huan, Dong, Lin, Zhang, Rumeng, Cheng, Xiao, Liu, Zexian, Ouyang, Yi, Ding, Keshuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531462/
https://www.ncbi.nlm.nih.gov/pubmed/34745455
http://dx.doi.org/10.1016/j.csbj.2021.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531462/
https://www.ncbi.nlm.nih.gov/pubmed/34745455
http://dx.doi.org/10.1016/j.csbj.2021.10.013

Ejemplares similares